EGFR and central nervous system cancer: Since IFN-γ can both inhibit the malignant phenotype of glioma cells and maintain the killing activity of immune cells, and EGFR serves as an important factor in glioma progression, it is necessary to explore the effect of IFN-γ on EGFR in gliomas.